Disruptive hip implant solution provides autonomy for life Orthonova commercialises a disruptive hip implant system for young patients in need of a hip surgery. Hip implants have a limited lifespan and young patients will have to replace their artificial hip before the end of their life. Classic implants are quite big and invasive, they sacrifice patients' bone and when they fail, a revision surgery can become a complex procedure with further clinical complications. Orthonova has solved this problem: Based on 30 years of clinical research, we have shown that our hip implant design is preserving young patients’ bone over time. As each patient is unique, Orthonova now provides a single use and patient specific instrumentation: "the surgery becomes simpler and safer than ever before" A perfect fit and bone conserving hip solution will last longer. Orthonova preserves young patients' autonomy for life.
| Website | http://www.orthonova.com/ |
| Revenue | $3 million |
| Employees | 5 (0 on RocketReach) |
| Founded | 2014 |
| Phone | +91 98146 44646 |
| Industry | Medical Devices, Surgical Devices, Outcome Management (Healthcare) |
| Keywords | Hip Implants, Hip Surgery, Hip Replacement, Total Hip Replacement, Orthopedic Surgery, Orthopedic Technology, Joint Replacement, Hip Resurfacing, Medical Devices, Disruptive Medical Technology, Surgical Implants, Bone Implants, Orthopedic Implants |
| Competitors | Medtronic, DePuy Synthes, Stryker, Boston Scientific, Zimmer Biomet, Smith+Nephew, CONMED Corporation, Aesculap (US), Ktm - Kühler Gmbh, Impulse Monitoring +31 more (view full list) |
Looking for a particular Orthonova employee's phone or email?
The Orthonova annual revenue was $3 million in 2026.